FORWARD FEATURES CALENDAR

Investments

Advent International to acquire significant stake in Dixcy

Private equity investor Advent International is to acquire a significant ownership interest in Dixcy Textiles Pvt Ltd (Dixcy), an innerwear brand in India. Dixcy’s Founder and Managing Director, Prem Prakash Sikka, will retain a stake in the company and continue as the Chairman following the completion of the transaction. Financial

Circulation raises USD10.5m in Series A financing

Circulation, the specialist in on-demand non-emergency healthcare transportation, has raised USD10.5 million in Series A financing from a syndicate of leaders across the healthcare ecosystem, excited to create a new paradigm for delivery of people, products and services in healthcare. Flare Capital Partners and The Providence Service Corporation (Providence), co-lead

Monroe Capital provides USD25m asset-based facility to Betteridge Jewelers

Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a USD25 million asset-based facility to refinance the existing debt facility and provide working capital for Betteridge Jewelers (Betteridge). Founded in 1897 and based in Greenwich, Connecticut, Betteridge is a premier jeweller and watch retailer

Ibotta closes C-1 Funding led by Silicon Valley-based GGV Capital

Popular US shopping app Ibotta has secured new funding led by Silicon Valley-based GGV Capital. This round furthers Ibotta’s mission of providing its consumers a Life Rewarded for making everyday purchases online, in mobile apps and at retail stores. With USD3.8 billion under management across eight funds, GGV has invested

Leesa Sleep raises USD23m

Leesa Sleep, a direct-to-consumer online luxury mattress retailer, has raised GBP17.6m in a Series B funding round led by One Better Ventures, an investment company led by John Replogle. Replogle will join Leesa as Chairman of the Board alongside Peter Graham who was Chairman of Seventh Generation until its recent sale

Allegro Ophthalmics secures USD10.7m in private financing

Allegro Ophthalmics, a biotechnology company focused on the development of novel therapies to treat vitreoretinal diseases has completed a private round of equity financing for USD10.7 million. With this infusion of capital, the company is strongly positioned to reach future corporate milestones. Allegro is . The company’s lead drug candidate,

Events

12 November, 2026 – 5:00 pm

Directory Listings